Home / Encorafenib / Austria
AT ATC L01EC03 · updated 2 Nov 2026
Encorafenib shortage in Austria
Is there an Encorafenib shortage in Austria?
Yes. As of 2 Nov 2026, 1 Encorafenib product is reported short in Austria, the first since 29 Oct 2026. The company estimate for the return is 15 Dec 2026. Main reason: increased demand.
Also short in Germany. All countries.
Affected products in Austria
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AT | Braftovi 75 mg Hartkapseln, 168 Stück | Pierre Fabre Medicament | 29 Oct 2026 | 15 Dec 2026 | Increased demand Erhöhter Mehrbedarf |
Source
BASG (Austrian Federal Office for Safety in Health Care). Official list. All reported restrictions, listed per pack (PZN).